~~<i id='B19A5D1261'><strike id='B19A5D1261'><tt id='B19A5D1261'><pre id='B19A5D1261'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：explore 2025-08-12 08:25:12 - browse：35

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Medicare wants to send $9 billion to 340B hospitals

hotspot

explore

entertainment

explore

entertainment

explore

InfectiousdiseaseexpertJeanneMarrazzowilltakeAnthonyFauci'sjobatoptheNationalInstitutesofAllergyandI

WSS

ACA's risk program benefits Blue Cross Blue Shield insurers

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

The U.S. needs a new definition of substance use “recovery”

Biden targets hefty hospital 'facility fees' that often surprise patients

Breakthrough Alzheimer’s drugs are inaccessible in rural states

hotspot

hotspot

hotspot

Jerome Adams on the need for new antivirals for Covid

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What to expect as Trump is arraigned on his Jan 6. indictment

Psychedelics group wrestles with new pharma identity

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Tori Bowie and the unacceptable rates of Black maternal death

Wildfire pollution widens asthma inequities on Long Island

What does generative AI mean for health care? We asked experts

Adults seen as increasingly susceptible to measles

explore

What to expect as Trump is arraigned on his Jan 6. indictment

Home health providers sue Medicare over payment cuts

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Biden targets hefty hospital 'facility fees' that often surprise patients

Adults seen as increasingly susceptible to measles

EQRx, failed developer of low

entertainment

explore

entertainment

explore